The comparative expression of full-length ACE2 to short dACE2 is also hypothesised to contribute to inter-individual variation in response to COVID-19, and it will be highly important to consider the role of this protein isoform in disease pathology and treatment. This evidence concerns the gene ACE2 and COVID-19.